Diabetes Mellitus News and Research

RSS
Diabetes mellitus is a severe and debilitating chronic disease that develops in nearly 5 percent of the world’s population. People with this disease have a shortage of insulin or a reduced ability to use insulin, the hormone regulating blood glucose levels, which is normally produced by the pancreas. In the United States alone, an estimated 18 million people have diabetes, and each year about 1 million Americans are diagnosed with the disease. It is the sixth leading cause of death in the US and is responsible for over 200,000 deaths a year. Insulin-dependent (type I) diabetes accounts for around 10% of diabetics. For those patients, suffering from an inability of their pancreas to produce insulin, the only practical treatment possible is regular insulin replacement by multiple daily injections. Transplantation of a pancreas or pancreatic tissue would be beneficial to millions of such patients in that it would restore their normal ability to produce self insulin. Transplantation of human pancreas or pancreatic islets is a practiced and time-honored such therapeutic approach, but is extremely limited by the severe shortage of human donor organs. Tissera's R&D efforts in this domain are directed towards the development of a universally available and reliable source of animal fetal donor pancreatic precursor tissue, suitable for transplantation and eventual normal structural and functional growth in human diabetics.
New tools for analyzing microbial communities

New tools for analyzing microbial communities

Does abdominal fat affect COVID-19 outcomes?

Does abdominal fat affect COVID-19 outcomes?

Study focuses on COVID-19 patients with inflammatory rheumatic diseases

Study focuses on COVID-19 patients with inflammatory rheumatic diseases

GlobalData: Diagnosed prevalent cases of angina pectoris expected to reach 22.79 million in 2028

GlobalData: Diagnosed prevalent cases of angina pectoris expected to reach 22.79 million in 2028

Diabetes type 3c is an early manifestation of pancreatic cancer, shows study

Diabetes type 3c is an early manifestation of pancreatic cancer, shows study

Indo-Mediterranean style diets can cause decline in pre-heart failure, arrhythmias

Indo-Mediterranean style diets can cause decline in pre-heart failure, arrhythmias

Hydroxychloroquine combined with azithromycin and abnormal heart rhythms in COVID-19 patients

Hydroxychloroquine combined with azithromycin and abnormal heart rhythms in COVID-19 patients

Study marks a major step towards beta cell replacement therapy

Study marks a major step towards beta cell replacement therapy

Preliminary findings on obesity and COVID-19 severity

Preliminary findings on obesity and COVID-19 severity

Brain insulin sensitivity linked to body weight and fat distribution

Brain insulin sensitivity linked to body weight and fat distribution

1.7 billion people at higher risk from COVID-19, study says

1.7 billion people at higher risk from COVID-19, study says

RAS inhibitors and COVID-19 severity in hypertensive patients

RAS inhibitors and COVID-19 severity in hypertensive patients

Specialized nerve cells promote the consumption of high-fat food

Specialized nerve cells promote the consumption of high-fat food

Poorer regions in the Philippines have more COVID-19 cases

Poorer regions in the Philippines have more COVID-19 cases

Women born by cesarean have greater risk of obesity and diabetes

Women born by cesarean have greater risk of obesity and diabetes

Healthy lifestyle, greater disease-free life expectancy

Healthy lifestyle, greater disease-free life expectancy

Mediterranean diet best for lowering LDL cholesterol

Mediterranean diet best for lowering LDL cholesterol

Medical teams need to be extra vigilant when dealing with diabetics during COVID-19 pandemic

Medical teams need to be extra vigilant when dealing with diabetics during COVID-19 pandemic

Higher serum EPA levels from prescription fish oil associated with lower cardiovascular events

Higher serum EPA levels from prescription fish oil associated with lower cardiovascular events

TWILIGHT trial: Brilinta reduces bleeding compared to dual therapy in high-risk coronary patients

TWILIGHT trial: Brilinta reduces bleeding compared to dual therapy in high-risk coronary patients